A study conducted in patients with chronic kidney disease (CKD), of whom 30% also suffered from T2D, showed a reduction in plasma apoM levels with severity of CKD in a cohort of more than 400 patients and 35 controls (32). The gene discussed is APOM; the disease is type 2 diabetes mellitus.